The NICE Guideline: Diagnosis and Management of the Menopause (NG23) plays an important role in raising awareness of all menopausal symptoms and treatment options.
The Guideline provides healthcare professionals with evidence-based information and enables women to better understand the consequences of the menopause and make informed choices about their treatment.
An updated Guideline is in development and the expected publication date is 23 August 2023. Further information can be found on the NICE website.
The British Menopause Society medical advisory council welcomed the publication of the NICE Guideline:
“We welcome the publication of this long awaited NICE guideline on the diagnosis and management of the menopause. The menopause affects all women and can have significant consequences both on impact of symptoms and later health problems. Despite this, many women are unaware of the effects and are confused about benefits and risks of treatment options.
“Our hope is that the guideline will play an important role in raising awareness of all menopausal symptoms, will encourage women to consider lifestyle changes to improve later health, and will clarify uncertainty around both prescribed and non-prescribed treatment options. Ultimately, we want both women and healthcare professionals to be empowered to make informed choices about menopause management and for much needed further research to ensue.”